Inventor · disambiguated record
Rafael Simó Canonge
Also filed as: SIMÓ CANONGE RAFAEL
8 granted patents·2 pending applications·5 citations·filing 2010–2022
76Inventor score
Files withFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA5FUNDACIÓ HOSPITAL UNIV VALL D'HEBRON-INSTITUT DE RECERCA2FUNDACIO HOSPITAL UNIV VALL DHERBRON INSTITUT DE RECERCA1RETINSET S L1SIMÓ CANONGE RAFAEL1
Top patents by PatentIndex Score
10 records- 0182US11013738B2Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodegenerative diseasesFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA·Filed 2017·Granted May 25, 2021·2 cites·12 claims
- 0267US9631030B2Administering antibodies or fragments thereof which bind hemopexin for the treatment of ocular diseasesFUNDACIÓ HOSPITAL UNIV VALL D'HEBRON—INSTITUT DE RECERCA·Filed 2013·Granted Apr 25, 2017·2 cites·19 claims
- 0365US11918577B2Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodegenerative diseasesFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA·Filed 2021·Granted Mar 5, 2024·0 cites·17 claims
- 0456US2025154197A1Lipolytic peptidesFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA·Filed 2022·Application pending·0 cites
- 0552US9216208B2Topical ophthalmic peptide formulationSIMÓ CANONGE RAFAEL·Filed 2010·Granted Dec 22, 2015·1 cites·9 claims
- 0650US10729634B2Sex hormone-binding globulin for use as a medicamentFUNDACIO HOSPITAL UNIV VALL DHEBRON—INSTITUT DE RECERCA·Filed 2014·Granted Aug 4, 2020·0 cites·4 claims
- 0740US9707273B2Peptides for use in the topical treatment of retinal neurodegenerative diseases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential roleFUNDACIÓ HOSPITAL UNIV VALL D'HEBRON—INSTITUT DE RECERCA·Filed 2014·Granted Jul 18, 2017·0 cites·21 claims
- 0839US2020138903A1Socs1-derived peptide for use in chronic complications of diabetesFUNDACIO HOSPITAL UNIV VALL DHERBRON INSTITUT DE RECERCA·Filed 2019·Application pending·0 cites
- 0937US10532082B2SOCS1-derived peptide for use in chronic complications of diabetesFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA·Filed 2015·Granted Jan 14, 2020·0 cites·15 claims
- 1024US10716750B2Topical ophthalmic formulations of endothelin receptor antagonistsRETINSET S L·Filed 2016·Granted Jul 21, 2020·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Rafael Simó Canonge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →